ArticlePolymers2022
Structure and Properties of Cellulose/Mycelium Biocomposites.
Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 26 citations in OpenAlex.
- Fungal Biotechnology for Sustainable Biocomposites: From Mycelium Growth to Material Translation.Molecules (Basel, Switzerland) · 2026Review
- Transforming Cellulose for Sustainability: Comprehensive Insights into Modification Approaches and Their Applications.ACS omega · 2026Review
- Study on the Properties and Design Applications of Polyester-Cotton Matrix Mycelium Composite Materials.Biomimetics (Basel, Switzerland) · 2025Article
- Natural Fibrous Materials Based on Fungal Mycelium Hyphae as Porous Supports for Shape-Stable Phase-Change Composites.Polymers · 2023Article
- Mycelium-based biomaterials as smart devices for skin wound healing.Frontiers in bioengineering and biotechnology · 2023Article
- Fungi in Mycelium-Based Composites: Usage and Recommendations.Materials (Basel, Switzerland) · 2022Review
- Multi-Organism Composites: Combined Growth Potential of Mycelium and Bacterial Cellulose.Biomimetics (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current environmental problems require the use of low-energy, environmentally friendly methods and nature-like technologies for the creation of materials. In this work, we aim to study the possibility of the direct biotransformation of fibrillar cellulose by fungi through obtaining a cellulose/mycelium-based biocomposite. The cellulose micro- and nanofibrils were used as the main carbon sources in the solid-phase cultivation of basidiomycete
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.